IGF1R and diabetes mellitus: The research by Wang and colleagues showed that miR-503 from M1 macrophage-released EVs inhibits insulin-like growth factor 1 receptor (IGF1R) expression in HUVECs, thereby impeding the wound healing process in individuals with diabetes (107).